About UroToday-GU Oncology Today®

About UroToday-GU Oncology Today®

 

UroToday - GU Oncology Today brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology. This site presents content on critical areas of research and clinical practice, providing researchers and clinicians the opportunity to evaluate original research, case studies, peer-peer video and podcast discussions, and relevant articles and commentaries.  

 

Since 2003 UroToday’s mission is to provide free, accurate, timely, evidence-based content to support healthcare providers in their need to stay at the forefront of understanding the dynamic advancements in improving patient outcomes.

Gina B. Carithers is the Founder and CEO of UroToday - GU OncToday, the UroToday International Journal, Everyday Urology - Oncology Insights, and recently GU OncToday all Digital Science Press publications. UroToday was launched in 2003 to establish an accessible platform designed to continuously change in our drive to stay at the forefront of the dynamic field of Genitourinary diseases and treatments.  UroToday offers content from conferences, publications, state of the art peer-to-peer lectures and conversations, and a listing of GU Oncology actively recruiting clinical trials.  With over 20 years at DuPont Pharmaceuticals, Ms. Carithers acquired a diversified experience in the commercialization strategies of pharmaceuticals.  For the past 19 years, she has been committed to developing innovative approaches to deliver the relevant content for interdisciplinary healthcare providers to be at the forefront of the dynamic areas of GU oncology, GU radiation oncology, and urology.  I remain passionate about continually improving our deliverables and inspired by the brilliant, committed, courageous, and focused medical practitioners who are contributors to the platform.  

We welcome your feedback and contributions towards continuing to make UroToday and GU OncToday an invaluable resource.
Please feel to contact us: 
email news signup